MyHealthChecked PLC At-home wellness tests to launch on Amazon (6462T)

TIDMMHC

RNS Number : 6462T

MyHealthChecked PLC

26 July 2022

MyHealthChecked PLC

( " MyHealthChecked " or the "Company " )

At-home wellness tests to launch on Amazon

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, announces that its suite of cheek- swab DNA at-home wellness tests will be available from today to purchase through the UK site of online retailer, Amazon.com, Inc. (NASDAQ: AMZN) ("Amazon").

The tests were initially launched by MyHealthChecked and available for purchase on the Company's website on 14 June 2022 . Customers will now be able to purchase four tests directly via Amazon UK, with the launch of the Glucose Management DNA test expected to follow. The tests will be priced at GBP54 per test, and will be delivered to users by Royal Mail Tracked 24.

The tests that will be available in MyHealthChecked's at-home wellness range and launching on Amazon are:

 
 Intolerances & Sensitivities   to identify genetic variants associated with intolerances, 
                                 such as gluten and lactose, as well as sensitivities, 
                                 including caffeine, salt and alcohol 
 Weight Management              intended for use by those wishing to identify their 
                                 genetic susceptibility to becoming overweight and 
                                 their responsiveness to weight loss interventions 
                                 at a molecular and metabolic level, including genetic 
                                 interactions 
 Heart Profile                  identifying how individuals respond differently 
                                 to diet. This will facilitate optimisation of heart 
                                 health parameters by using personalised dietary 
                                 advice 
 Vitamins & Minerals            this test indicates the predisposition towards 
                                 a nutrient deficiency or toxicity, to highlight 
                                 nutrients or supplements an individual should increase 
                                 or deprioritise

MyHealthChecked's range of at-home wellness tests allow individuals to make more informed choices about their health and well-being from personalised, accurate results and advice. Understanding genetic disposition provides individuals with the power to be proactive about their health and well-being through lifestyle and diet management, allowing individuals to fully unlock their health potential.

The launch of the tests via Amazon supports the Company's strategy of accessible healthcare for all, enabling the Company to broaden its reach, as the demand for health and wellness tests expands. All tests will continue to be available via the MyHealthChecked website ( www.myhealthchecked.com/wellness ), also priced at GBP54 per test, which also provides access to information about the benefits of DNA use, details of the Scientific Advisory team and full customer facts and questions.

Penny McCormick, Chief Executive Officer of MyHealthChecked Plc , said: "We are excited to be launching our wellness tests with Amazon and believe this will greatly increase the accessibility of our product range. Following the success of our partnership with the UK's top high street pharmacy retailers for our COVID testing service, we have seen the real value that additional retail partners can bring to the business by broadening our customer base and significantly increasing our market share."

For further information contact:

 
 MyHealthChecked plc                                                www.myhealthchecked.com 
 P enny McCormick, Chief Executive                                          via Walbrook PR 
  Officer 
 
 SPARK Advisory Partners Limited                                   Tel: +44 (0)20 3368 3550 
  (NOMAD) 
 Neil Baldwin 
 
 Oberon Capital Ltd (Broker)                                       Tel: +44 (0)20 3179 5344 
 Mike Seabrook                                           mikeseabrook@oberoninvestments.com 
 
 Walbrook PR Ltd (Media       Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com 
  & IR) 
 Paul McManus / Alice Woodings                             Mob: +44(0)7980 541 893 / +44(0) 
                                                                               7407 804 654

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUVRURUWUBUAR

(END) Dow Jones Newswires

July 26, 2022 02:00 ET (06:00 GMT)

Concepta (LSE:CPT)
過去株価チャート
から 10 2024 まで 11 2024